Artificial structures of tumour antigens, so-called mimotopes, applied in vaccinations of cancer patients can trigger a long-term immune response. For the vaccine, however, a carrier is required that triggers an immune response ...
Oct 11, 2016
0
1
A phase III randomized controlled trial of custirsen in combination with cabazitaxel/prednisone in patients with previously-treated metastatic, castration-resistant prostate cancer has shown no significant survival gains ...
Oct 10, 2016
0
0
Researchers funded by the Medical Research Council (MRC) have shown that when the metabolite fumarate accumulates in a hereditary form of renal cancer it leads to an epigenetic reprogramming that drives cancer, according ...
Aug 31, 2016
0
3
Research has shown that the growth of cancerous tumours is affected by transforming growth factor (TGFβ) in the body's cells; TGFβ both suppresses and stimulates tumour development. But it has not been understood how this ...
Aug 23, 2016
0
0
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität (FAU) aim to find answers ...
Jul 11, 2016
0
1
A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European ...
Jul 3, 2016
1
6
It is hard to believe that some cancers miraculously disappear, but it does happen. Over 1,000 case studies document cancer sufferers who experienced spontaneous regression of their tumour. So why does this happen and is ...
Jun 17, 2016
0
30
Queensland researchers have discovered that the first-stage response of the immune system can contribute to melanoma, colon and breast cancer growth, rather than helping the body to fight it.
Jun 14, 2016
0
7
Researchers from the Breast Cancer Clinical Research Unit at the Spanish National Cancer Research Centre (CNIO) have just published an important finding regarding antiangiogenic drugs, one of the most commonly used drugs ...
Jun 9, 2016
0
2
A team of Walter and Eliza Hall Institute researchers has worked out how a new class of anti-cancer drugs kills cancer cells, a finding that helps explain how cancer cells may become resistant to treatment.
May 20, 2016
0
101
